- Home
- YYAI vs CING Comparison
YYAI vs CING Comparison
Compare YYAI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYAI
- CING
- Stock Information
- Founded
- YYAI 2015
- CING 2012
- Country
- YYAI Hong Kong
- CING United States
- Employees
- YYAI N/A
- CING N/A
- Industry
- YYAI
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- YYAI
- CING Health Care
- Exchange
- YYAI NYSE
- CING Nasdaq
- Market Cap
- YYAI 12.1M
- CING 15.3M
- IPO Year
- YYAI N/A
- CING 2021
- Fundamental
- Price
- YYAI $0.96
- CING $4.30
- Analyst Decision
- YYAI
- CING Strong Buy
- Analyst Count
- YYAI 0
- CING 4
- Target Price
- YYAI N/A
- CING $30.67
- AVG Volume (30 Days)
- YYAI 244.5K
- CING 94.3K
- Earning Date
- YYAI 03-24-2025
- CING 05-07-2025
- Dividend Yield
- YYAI N/A
- CING N/A
- EPS Growth
- YYAI N/A
- CING N/A
- EPS
- YYAI N/A
- CING N/A
- Revenue
- YYAI N/A
- CING N/A
- Revenue This Year
- YYAI N/A
- CING N/A
- Revenue Next Year
- YYAI N/A
- CING N/A
- P/E Ratio
- YYAI N/A
- CING N/A
- Revenue Growth
- YYAI N/A
- CING N/A
- 52 Week Low
- YYAI $0.35
- CING $1.80
- 52 Week High
- YYAI $21.60
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- YYAI 63.56
- CING 57.30
- Support Level
- YYAI $0.70
- CING $4.03
- Resistance Level
- YYAI $0.90
- CING $4.44
- Average True Range (ATR)
- YYAI 0.09
- CING 0.29
- MACD
- YYAI 0.02
- CING 0.05
- Stochastic Oscillator
- YYAI 90.75
- CING 74.38
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.